First-in-human, dose escalation, phase I study of an antibody-based immunotherapy in patients with solid tumor (Kopie)
Deadline:05 Dec 2024, 00:00 CET
Tender information
TED EULeipzig, Germany
- Type
- 16
- Procedure
- neg-w-call
- Ref. number
- 703616-2024
- CPV
- 85145000
Conduct of a multicenter, first-in-human, dose escalation, phase I study of an antibody-based immunotherapy in patients with solid tumor (basket trial).